Neuroprotective Effect of Gypenosides against Oxidative Injury in the Substantia Nigra of a Mouse Model of Parkinson's Disease

By Wang P   Niu L   Gao L   Li W-X   Jia D   Wang X-L   Gao G-D  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1084-1092

Field House Publishing

Access to resources Recommend Favorite

Chlorotoxin-modified stealth liposomes encapsulating levodopa for the targeting delivery against the Parkinson’s disease in the MPTP-induced mice model

By Xiang Yu   Wu Qian   Liang Liang   Wang Xueqing   Wang Jiancheng   Zhang Xuan   Pu Xiaoping   Zhang Qiang  

Journal of Drug Targeting, Vol. 20, Iss. 1, 2012-01 ,pp. : 67-75

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory Process as a Determinant Factor for the Degeneration of Substantia Nigra Dopaminergic Neurons: Possible Relevance to the Etiology of Parkinson's Disease

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 4, 2004-12 ,pp. : 223-233

Bentham Science Publishers

Access to resources Recommend Favorite

ORGANOCHLORINE INSECTICIDES IN SUBSTANTIA NIGRA IN PARKINSON'S DISEASE

By Corrigan F.M.   Wienburg C.L.   Shore R.F.   Daniel S.E.   Mann D.  

Journal of Toxicology and Environmental Health, Vol. 59, Iss. 4, 2000-02 ,pp. : 229-234

Taylor & Francis Ltd

Access to resources Recommend Favorite

Protection of Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease by a Physically-Modified Saline Containing Charge-Stabilized Nanobubbles

By Khasnavis Saurabh   Roy Avik   Ghosh Supurna   Watson Richard   Pahan Kalipada  

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 218-232

Springer Publishing Company

Access to resources Recommend Favorite